In The Media

"I think a lot of the kind of open questions surrounding these vaccines are the reason that we have that shared clinical decision making component for now." (Keri Hurley-Kim)

"In high quality studies, the quality of curcumin that is being used is evaluated by the researchers, so unless consumers use the same exact formulation that was used in such studies, they may not see the same results." (Mahtab Jafari)

"This study may also influence the first medication prescribed with weight loss in mind, prompting prescribers to favor tirzepatide (Mounjaro) over semaglutide (Ozempic)." (Sarah McBane)

"The prescribing information for all of these medications states that there is the potential to affect the absorption and efficacy of oral medications." (Sarah McBane)

"Before now, there hasn’t been much information available on patient-level, longitudinal use patterns, and the recent FDA approval of GLP-1 RAs linked to substantial weight loss has generated great interest in demand projections." (Jonathan Watanabe)

"It still needs to be evaluated what that actually turns out in terms of dollars." (Jonathan Watanabe)